{
  "type": "reply",
  "timestamp": "2025-12-10T20-42-03-896Z",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "endpoint": "findRelevantGuidelines-chunk-5",
  "token_usage": null,
  "prompt_length": 1298,
  "response_length": 1531,
  "prompt_preview": "{\"prompt\":\"Chunk 5/38\",\"transcriptLength\":120,\"transcriptPreview\":\"how should we counsel a patient regarding their options with regard to delivery for GIDDM with macrosomia at 40+1 weeks?...\",\"chunkGu...",
  "response_preview": "{\n  \"success\": true,\n  \"aiResponse\": \"{\\n  \\\"mostRelevant\\\": [],\\n  \\\"potentiallyRelevant\\\": [],\\n  \\\"lessRelevant\\\": [{\\\"id\\\": \\\"bjog-2022-stock-antenatal-corticosteroids-to-reduce-neonatal-morbidity...",
  "full_data": null
}